Salivary gland neoplasms are a morphologically heterogenous group of lesions that are
often diagnostically challenging. In recent years, considerable progress in salivary gland …

Advances in medical sciences and evidence-based medicine have led to momentous
changes in classification and management of thyroid neoplasms. Much progress has been …

ETV6 gene abnormalities are well described in tumor pathology. Many fusion partners of
ETV6 have been reported in a variety of epithelial, mesenchymal, and hematological …

Purpose: Salivary duct carcinoma (SDC) is an aggressive salivary malignancy, which is
resistant to chemotherapy and has high mortality rates. We investigated the molecular …

Background: Secretory carcinoma (SC), originally described as mammary analogue SC, is a
predominantly low-grade salivary gland neoplasm characterized by a recurrent t (12; …

Intraductal carcinoma (IC) is the new World Health Organization designation for tumors
previously called “low-grade cribriform cystadenocarcinoma” and “low-grade salivary duct …

Secretory carcinoma of the salivary glands, also known as mammary analogue secretory
carcinoma, is a recently described tumor characterized by generally indolent clinical …

Intraductal carcinoma (IC) is the World Health Organization designation for lesions
previously called low-grade cribriform cystadenocarcinoma. The relationship of IC to salivary …

Secretory carcinoma (SC) of the salivary gland is a low-grade malignancy associated with a
well-defined clinical, histologic, immunohistochemical, and cytogenetic signature. Although …

This current review focuses on current concepts and controversies for select key salivary
gland epithelial neoplasms. Rather than the traditional organization of benign and malignant …